Evidence map›Paper›PMID 41368042›Full record

ArticleFrontiers in allergy2025

Combined exposure to shrimp tropomyosin and microbial components triggers enhanced allergic and inflammatory responses

Fikirte Debebe Zegeye, Steen Mollerup, Mayes Alswady-Hoff, Annette Kuehn, Sabina Burla, Anne Straumfors, Johanna Samulin Erdem

Abstract read
In one paragraph

Article in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fikirte Debebe ZegeyeDepartment of Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway.
Steen MollerupDepartment of Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway.
Mayes Alswady-HoffDepartment of Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway.
Annette KuehnDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Sabina BurlaINVITROLIZE, Esch-sur-Alzette, Luxembourg.
Anne StraumforsDepartment of Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway.
Johanna Samulin ErdemDepartment of Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Workers in the shellfish industry face increased risks of allergy and asthma due to complex bioaerosol exposures in the workplace. This study aimed to assess whether combined exposure to the main components of these aerosols, specifically allergens and microbial agents, can potentiate inflammatory and allergic responses. Methods: THP-1 monocytes and advanced human alveolar co-cultures model ALIsens® were exposed to shrimp tropomyosin (0.0049, 1.3 and 2.6 µg/mL), and components from Gram-positive bacteria; lipoteichoic acid (0.25-4 µg/mL), and fungi; zymosan (6.25-100 µg/mL), either alone or in combination. The effects on the gene expression and protein secretion of chemokines and cytokines were assessed by RT-qPCR and ELISA or Luminex. Results: Combined exposure to tropomyosin and lipoteichoic acid resulted in increased Conclusion: These findings suggest that microbial components in shellfish industry bioaerosols may enhance the immunological responses caused by inhaled allergens in an additive manner, highlighting the need to minimise microbial contamination in workplaces where allergen exposure is prevalent.

Indexed as

additive effectsallergensallergybioaerosol exposureinflammationmicrobial componentsoccupational exposuretropomyosin

Identifiers

PMID41368042
PMCPMC12683351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.